NSC |
Compound |
Enrichment |
Correlation |
NSC 732837 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene |
0.00433056621075589 |
0.18799603 |
NSC 743862 |
Null |
0.00433056621075589 |
0.23101434 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.00567322425730621 |
0.3572972 |
NSC 13151 |
Null |
0.00567322425730621 |
0.31595327 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.00567322425730621 |
0.1752815 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00567322425730621 |
0.45357175 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.00567322425730621 |
0.091644719 |
NSC 18805 |
.gamma.-Thujaplicine |
0.00567322425730621 |
0.39381108 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.00567322425730621 |
0.15372201 |
NSC 339579 |
7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate |
0.00567322425730621 |
0.31559054 |